Alterations of the WNT7A gene in clear cell renal cell carcinomas

Aleksandr G Kondratov1, Sergiy M Kvasha, Liubov A Stoliar

  • 1Department of Molecular Oncogenetics, Institute of Molecular Biology and Genetics, National Academy of Science, Kyiv, Ukraine. o.g.kondratov@imbg.org.ua

Plos One
|October 12, 2012
PubMed

Insights

The WNT7A gene, a tumor suppressor, is frequently silenced by hypermethylation in clear cell renal cell carcinomas (RCC). This inactivation correlates with tumor progression and WNT7A demonstrates tumor suppressor functions in RCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • WNT7A is a known tumor suppressor gene in non-small cell lung carcinomas (NSCLC).
  • WNT gene family members are crucial in cell signaling and cancer development.
  • CpG-island hypermethylation frequently inactivates tumor suppressor genes in human cancers.

Purpose of the Study:

  • To investigate the role of WNT7A gene inactivation in clear cell renal cell carcinoma (RCC).
  • To determine the frequency and correlation of WNT7A hypermethylation with clinicopathological features in RCC.
  • To confirm the tumor suppressor function of WNT7A in RCC.

Main Methods:

  • Methyl-specific PCR (MSP) and bisulfite sequencing to detect WNT7A hypermethylation.
  • Analysis of correlations between WNT7A hypermethylation and tumor stage/Fuhrman nuclear grade.
  • 5-aza-2'-deoxycytidine treatment to restore WNT7A expression and functional assays (colony formation, proliferation) to assess tumor suppressor activity.

Main Results:

  • WNT7A hypermethylation was detected in 66% of clear cell RCCs and correlated with advanced tumor stage and higher Fuhrman nuclear grade.
  • Bisulfite sequencing confirmed intensive 5'-CpG island hypermethylation of WNT7A.
  • WNT7A gene expression was down-regulated in 88% of clear cell RCCs, with restoration observed after 5-aza-2'-deoxycytidine treatment.
  • Loss of heterozygosity (LOH) was frequent on chromosome 3p25.
  • WNT7A demonstrated tumor suppressor function in RCC cell lines.

Conclusions:

  • The WNT7A gene is frequently inactivated by genetic and epigenetic alterations in clear cell RCC.
  • WNT7A hypermethylation is a significant event in RCC pathogenesis, correlating with disease progression.
  • WNT7A acts as a tumor suppressor in clear cell renal cell carcinoma.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...